AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
+0.21%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$251M
AUM Growth
+$251M
(+20%)
Cap. Flow
+$50.5M
Cap. Flow
% of AUM
20.08%
Top 10 Holdings %
Top 10 Hldgs %
47.89%
Holding
91
New
17
Increased
26
Reduced
12
Closed
13
Top Buys
Top Sells
| 1 |
Protagonist Therapeutics
PTGX
|
$6.29M |
| 2 |
Zentalis Pharmaceuticals
ZNTL
|
$4.33M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$3.38M |
| 4 |
MacroGenics
MGNX
|
$2.15M |
| 5 |
ESSA Pharma
EPIX
|
$2M |
Sector Composition
| 1 | Healthcare | 88.08% |
| 2 | Financials | 6.33% |
| 3 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cullinan Oncology
CGEM
$456M
| – | – |
-45,000
| Closed | -$1.16M |
|
77
Axsome Therapeutics
AXSM
$6.09B
| – | – |
-25,000
| Closed | -$1.69M |
|
78
ARK Genomic Revolution ETF
ARKG
$1.05B
| – | – |
0
| – | – |
|
79
Apellis Pharmaceuticals
APLS
$3.51B
| – | – |
-10,000
| Closed | -$632K |
|
80
Alnylam Pharmaceuticals
ALNY
$58.6B
| – | – |
0
| – | – |
|
81
Mersana Therapeutics
MRSN
$34.8M
| – | – |
-85,000
| Closed | -$1.15M |
|
82
Moderna
MRNA
$9.36B
| – | – |
0
| – | – |
|
|
83
MacroGenics
MGNX
$121M
| – | – |
-80,000
| Closed | -$2.15M |
|
84
KalVista Pharmaceuticals
KALV
$713M
| – | – |
-50,000
| Closed | -$1.2M |
|
|
ITOS
85
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-25,000
| Closed | -$641K |
|
86
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
0
| – | – |
|
87
Immunovant
IMVT
$2.91B
| – | – |
0
| – | – |
|
|
88
ESSA Pharma
EPIX
$11.2M
| – | – |
-70,000
| Closed | -$2M |
|
89
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|